TNFR:Fc

DRUG9 trials

Conditions

Ankylosing spondylitis (AS).Arthritis, Juvenile RheumatoidAsthmaPsoriasis Subjects with Psoriatic ArthritisPsoriasis and Psoriatic ArthritisRheumatoid ArthritisSubjects with Ankylosing Spondylitis (AS)Uveitis

Phase 2

Study of TNFR:Fc (Enbrel) in the Treatment of Asthma

CompletedNCT00001893

National Heart, Lung, and Blood Institute (NHLBI)Asthma

Start: 1999-08-17Target: 150Updated: 2017-07-02

Phase 3

The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis

NCT00012506

National Eye Institute (NEI)Arthritis, Juvenile Rheumatoid, Uveitis

Updated: 2005-06-24

A Randomised, Double-Blind Study Comparing the Safety and Efficacy of Etanercept with Sulphasalazine in Subjects with Ankylosing Spondylitis - ASCEND

Active, not recruitingEUCTR2005-001549-41-HU

Wyeth Research Division of Wyeth Pharmaceuticals IncSubjects with Ankylosing Spondylitis (AS)

Start: 2005-11-25Target: 525Updated: 2021-12-21

Phase 4

Etanercept in Psoriasis and Psoriatic Arthritis: a single center, open-label study in 15 patients.

Active, not recruitingEUCTR2004-004691-37-IE

St Vincents University HospitalPsoriasis and Psoriatic Arthritis

Target: 15Updated: 2025-04-14

An open-label, multicentre, supplementary and extension study of Etanercept in subjects with Ankylosing Spondylitis (AS)

Active, not recruitingEUCTR2006-001061-42-GB

Wyeth Pharmaceuticals France, Wyeth Research DivisionAnkylosing spondylitis (AS).

Start: 2006-07-31Target: 108Updated: 2019-11-25

Unknown Phase

A 24-MONTH, RANDOMIZED, DOUBLE-BLIND, TWO PERIOD STUDY TO EVALUATE THE EFFICACY AND SAFETY OF THE COMBINATION OF ETANERCEPT AND METHOTREXATE AND METHOTREXATE ALONE IN SUBJECTS WITH ACTIVE EARLY RHEUMATOID ARTHRITIS: COMBINATION OF METHOTREXATE AND ETANERCEPT IN ACTIVE EARLY RHEUMATOID ARTHRITIS (COMET) - COMET

Active, not recruitingEUCTR2004-000563-96-HU

Wyeth PharmaceuticalsRheumatoid Arthritis

Start: 2004-11-12Target: 580Updated: 2012-05-29

A Randomized, Open Label Study to Evaluate the Safety and Efficacy of Etanercept in the Treatment of Subjects with Psoriasis - CLEAREST

Active, not recruitingEUCTR2004-002629-36-HU

Wyeth Pharmaceuticals, Global Medical Affairs Departmentpsoriasis

Start: 2005-02-01Target: 700Updated: 2012-05-01

A Randomized, Open Label Study to Evaluate the Safety and Efficacy of Etanercept in the Treatment of Subjects with Psoriasis - CLEAREST

Active, not recruitingEUCTR2004-002629-36-HU

Wyeth Pharmaceuticals, Global Medical Affairs Departmentpsoriasis

Start: 2005-02-01Target: 700Updated: 2012-05-01

A Randomised, Double-Blind, Two-Period Study to Evaluate the Safety and Efficacy of Etanercept on Skin and Joint Disease in Psoriasis Subjects with Psoriatic Arthritis

Active, not recruitingEUCTR2005-001533-15-HU

Wyeth Research Division of Wyeth Pharmaceuticals IncPsoriasis Subjects with Psoriatic Arthritis

Start: 2005-10-06Target: 800Updated: 2012-04-18

A Randomised, Double-Blind, Two-Period Study to Evaluate the Safety and Efficacy of Etanercept on Skin and Joint Disease in Psoriasis Subjects with Psoriatic Arthritis - PRESTA

Active, not recruitingEUCTR2005-001533-15-FI

Global Medical Affairs, Wyeth Research Division of Wyeth Pharmaceuticals IncPsoriasis Subjects with Psoriatic Arthritis